First Citizens BancShares, Inc. Depositary Shares, each representing a 1/40th interest in a share of 6.625% Non-Cumulative Perpetual Preferred Stock, Series E (FCNCN) 股票分析
First Citizens BancShares, Inc. Depositary Shares, each representing a 1/40th interest in a share of 6.625% Non-Cumulative Perpetual Preferred Stock, Series E
$25.11
$-0.02 (-0.08%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
First Citizens BancShares, Inc. Depositary Shares, each representing a 1/40th interest in a share of 6.625% Non-Cumulative Perpetual Preferred Stock, Series E (ticker FCNCN) is a financial instrument issued by First Citizens BancShares, Inc. Although specific business descriptions for the underlying entity are not available in the provided data, the instrument functions as a perpetual preferred stock security rather than a common equity share. The company operates within the financial sector, specifically engaging in banking activities that provide capital and liquidity services, though the precise industry classification remains unlisted in the available facts. The market capitalization for this security is listed as N/A, indicating that standard equity valuation metrics may not apply or are not disclosed in the current reporting framework. Similarly, the annual revenue, total employee count, and specific sector industry designation are all recorded as N/A, which limits the ability to assess the firm's operational scale through traditional common stock metrics. Consequently, the available data suggests that valuation and operational scale must be interpreted through the lens of preferred equity characteristics rather than standard banking sector benchmarks. The absence of a defined market cap and revenue figure implies that the investor's exposure is strictly limited to the dividend stream and potential capital appreciation of the depositary shares, without the accompanying revenue generation data typically associated with common equities. This lack of disclosed scale metrics reinforces the nature of the security as a specialized instrument where traditional size indicators are either not applicable or not publicly reported for this specific series.
财务健康
The revenue, net income, and EBITDA figures for this security are all reported as N/A, meaning that the gap between top-line revenue and net income cannot be calculated to reveal the underlying cost structure for this specific preferred stock tranche. Because the financial metrics for revenue and EBITDA are not disclosed, it is impossible to state the free cash flow figures, and therefore no assessment of the company's financial flexibility can be made based on the provided data. The gross margin, operating margin, and profit margin are all listed as N/A, precluding any analysis of how efficiently the company converts sales into profits at various stages of its operations. With total cash, total debt, and the debt-to-equity ratio all marked as N/A, a comparison of liquidity assets against liabilities is not possible, and the balance sheet cannot be characterized as conservative or leveraged using the available information. Furthermore, the current ratio is unavailable, which prevents an evaluation of the company's ability to meet short-term obligations with its short-term assets. The return on equity and return on assets metrics are also not provided, making it impossible to explain what these return metrics reveal about management effectiveness in generating returns on the capital employed.
估值评估
The trailing P/E ratio and forward P/E ratio for FCNCN are both listed as N/A, which prevents an explanation of the difference between them regarding expected earnings trajectory or future growth expectations. The price-to-book ratio is not disclosed, so there is no data to indicate whether the market is applying a premium or discount to the company's book value per share. Similarly, the price-to-sales ratio and EV/EBITDA multiple are unavailable, meaning alternative valuation metrics cannot be used to suggest the relative value of the security compared to its peers or intrinsic value. The 52-week high is recorded at $25.29 and the 52-week low is recorded at $23.74; without a specific current price point provided in the facts, the current trading position relative to this range cannot be calculated or stated. The beta value is listed as N/A, which precludes any explanation of the security's price volatility relative to the broader market movements.
Growth & Income
The revenue growth rate and earnings growth rate year-over-year are both reported as N/A, making it impossible to state whether earnings are growing faster or slower than revenue or to explain the implications of such a growth dynamic. Since the dividend yield and payout ratio are listed as N/A, no analysis can be conducted on the sustainability of dividend payments given the company's earnings performance. The available facts do not explicitly confirm or deny dividend status through a yield figure, but the absence of a dividend yield metric suggests that standard dividend income calculations are not applicable or reported for this specific security class in the current dataset. Consequently, the overall growth and income profile cannot be summarized with specific quantitative data points, as the necessary metrics for growth rates and income generation are entirely absent from the provided information.
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
关键指标
- 市值
- N/A
- 市盈率
- N/A
- 52周最高
- $25.36
- 52周最低
- $23.74
- 平均成交量
- 51.38K
数据由Yahoo Finance通过yfinance提供。每日更新。
公司信息
- 交易所
- NASDAQ